Summary

Eligibility
for people ages 18-60 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Mandana Khalili
Headshot of Mandana Khalili
Mandana Khalili

Description

Summary

The study hypothesis is that the means by which HCV induces glucose intolerance is through impairment of B-cell function and compensatory hyperinsulinemia in predisposed Latinos with insulin resistance and that HCV eradication improves these abnormalities. It is also hypothesized that moderate alcohol consumption impact insulin sensitivity and secretion with Latinos with or without HCV infection.

Official Title

Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos

Details

The study hypothesis is that the means by which HCV induces glucose intolerance is through impairment of B-cell function and compensatory hyperinsulinemia in predisposed Latinos with insulin resistance and that HCV eradication improves these abnormalities. This study addresses changes in the metabolic parameters over time. In addition, it is hypothesized that moderate alcohol consumption impacts insulin resistance and secretion and 30 patients with or without HCV who drink alcohol moderately will have discontinuation of alcohol use for 6 weeks and have metabolic testing before and after alcohol discontinuation.

Keywords

Insulin Resistance, Moderate alcohol cessation, HCV infection

Eligibility

Location

  • UCSF
    San Francisco California 94110 United States

Lead Scientist at UCSF

  • Mandana Khalili
    Chief of Clinical Hepatology, San Francisco General Hospital Director, Clinical and Translational Research in Hepatology, San Francisco General Hospital Director, Investigator Development Unit, UCSF Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases (Health Equity Action Network) Co-Director, UCSF Mentor Training Program Co-Director, UCSF T32 Hepat…

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT01858012
Study Type
Observational
Participants
Expecting 250 study participants
Last Updated